pLSB-NAT Citations (3)
Originally described in: SpEDIT: A fast and efficient CRISPR/Cas9 method for fission yeast.Torres-Garcia S, Di Pompeo L, Eivers L, Gaborieau B, White SA, Pidoux AL, Kanigowska P, Yaseen I, Cai Y, Allshire RC Wellcome Open Res. 2020 Nov 24;5:274. doi: 10.12688/wellcomeopenres.16405.1. eCollection 2020. PubMed Journal
Articles Citing pLSB-NAT
| Articles |
|---|
| Proteasome-dependent truncation of the negative heterochromatin regulator Epe1 mediates antifungal resistance. Yaseen I, White SA, Torres-Garcia S, Spanos C, Lafos M, Gaberdiel E, Yeboah R, El Karoui M, Rappsilber J, Pidoux AL, Allshire RC. Nat Struct Mol Biol. 2022 Aug;29(8):745-758. doi: 10.1038/s41594-022-00801-y. Epub 2022 Jul 25. PubMed |
| CRISPR-Cas9 targeting of G-Quadruplex DNA in ADH1 promoter highlights its role in transcriptome and metabolome regulation. Obi I, Sengupta P, Sabouri N. Nucleic Acids Res. 2025 Sep 5;53(17):gkaf853. doi: 10.1093/nar/gkaf853. PubMed |
| Actin arginylation alters myosin engagement and F-actin patterning despite structural conservation. Pinto CS, Bakker SE, Suchenko A, Kolodny IM, Hussain H, Hatano T, Sampath K, Chinthalapudi K, Heissler SM, Mishima M, Balasubramanian M. J Cell Biol. 2026 Jan 5;225(1):e202409067. doi: 10.1083/jcb.202409067. Epub 2025 Nov 14. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.